Literature DB >> 7645165

Periurethral injection of collagen in the treatment of intrinsic sphincteric deficiency in the female patient.

J C Winters1, R Appell.   

Abstract

In properly selected patients, the periurethral injection of collagen is a safe and effective form of management for females with intrinsic sphincteric dysfunction. Performed under local anesthesia, this procedure allows for the treatment of patients who may not be suitable candidates for anesthesia and formal surgery. In female patients, excellent treatment results are obtained, which appear durable for greater than 2 years; these results are obtained usually within three treatment sessions. Periurethral collagen injection has been shown to elicit only a minimal inflammatory reaction and there have been no adverse immunogenic effects, foreign-body reaction, or migration of the injected material. Adverse events associated with the periurethral injection of collagen are rare. Collagen has proven to be a highly efficacious substance for use in periurethral injections for the treatment of intrinsic sphincteric dysfunction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7645165

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  9 in total

1.  Current use of injectable agents for female stress urinary incontinence.

Authors:  Sender Herschorn
Journal:  Rev Urol       Date:  2005

2.  The effect of local anaesthetic infiltration on urethral function during the tension-free vaginal tape (TVT) procedure.

Authors:  Jonathan R A Duckett; Nick S Papanikolaou; Maria Eaton
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06

3.  Case reports: periurethral bulking agents and presumed urethral diverticula.

Authors:  Disha Kumar; Melissa R Kaufman; Roger R Dmochowski
Journal:  Int Urogynecol J       Date:  2011-02-22       Impact factor: 2.894

Review 4.  Periurethral collagen injection for male and female sphincteric incontinence: indications, techniques, and result.

Authors:  E J McGuire; S F English
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

5.  Factors influencing the long-term success of periurethral collagen therapy in the office.

Authors:  Sumana Koduri; Roger P Goldberg; Christina Kwon; Deborah G Dobrez; Peter K Sand
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-10-14

6.  Collagen injections for genuine stress urinary incontinence: patient selection and durability.

Authors:  S Herschorn; S B Radomski
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

7.  Ultrasonography as a screening tool for paravaginal defects in women with stress incontinence: a pilot study.

Authors:  A Ostrzenski; N G Osborne
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

Review 8.  Emerging periurethral bulking agents for female stress urinary incontinence: is new necessarily better?

Authors:  Jonathan S Starkman; Harriette Scarpero; Roger R Dmochowski
Journal:  Curr Urol Rep       Date:  2006-09       Impact factor: 2.862

Review 9.  Use of collagen for the treatment of stress urinary incontinence: an update.

Authors:  M B Tchetgen; R A Appell
Journal:  Curr Urol Rep       Date:  2000-10       Impact factor: 2.862

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.